Literature DB >> 11693816

Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.

P H Sugarbaker1.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11693816

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


× No keyword cloud information.
  6 in total

1.  Pseudomyxoma peritonei: unusual origin from an ovarian mature cystic teratoma.

Authors:  N Pranesh; L P Menasce; M S Wilson; S T O'Dwyer
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

2.  Clinical significance of heat shock proteins in gastric cancer following hyperthermia stress: Indications for hyperthermic intraperitoneal chemoperfusion therapy.

Authors:  Yinuo Tu; Yunhong Tian; Yinbing Wu; Shuzhong Cui
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

3.  Pseudomyxoma peritonei: a rare tumour mimicking primary ovarian neoplasia.

Authors:  Cátia Filipa Martins; Sara Costa; Pedro Guedes; Ana Filipa Rafael
Journal:  BMJ Case Rep       Date:  2015-03-05

4.  MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin.

Authors:  Xiang-Liang Zhang; Hui-Juan Shi; Ji-Ping Wang; Hong-Sheng Tang; Yin-Bing Wu; Zhi-Yuan Fang; Shu-Zhong Cui; Lian-Tang Wang
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei.

Authors:  Lei Liang; Jingyang Fang; Xuedi Han; Xichao Zhai; Yan Song; Yiyan Lu; Qian Zhang; Ruiqing Ma
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

6.  Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis.

Authors:  Yunzi Wu; Xiaohao Zheng; Chunyang Sun; Shenghui Wang; Shikang Ding; Ming Wu; Jing Zhang; Bingzhi Wang; Liyan Xue; Lin Yang; Yantao Tian; Yibin Xie
Journal:  BMC Surg       Date:  2022-09-18       Impact factor: 2.030

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.